在猪模型中用Hydroxocobalamin治疗nifedipine诱导的冲击的有效性
Christine Murphy1, Michael Runyon2, Michael Gellar2
1Atrium Health's Carolinas Medical Center, Charlotte, NC, USA. Christine.Murphy66@gmail.com.
概括
在尼菲迪平过量服用的猪模型中,氧巴胺改善了血液动力学,但并没有降低死亡率. 这表明可胺可能有助于稳定患者在关键过量事件期间.
科学领域:
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 通道抗剂是过量死亡的主要原因.
- 对于通道阻塞毒性存在有限的治疗选择.
- 氧巴胺显示出逆转冲击状态的潜力.
研究的目的:
- 评估氧巴胺在治疗尼菲迪平诱导的休克时的疗效.
- 评估过量剂量的猪模型中的血液动力学变化和死亡率.
主要方法:
- 22只猪被用来模拟尼菲迪平诱导的休克.
- 在达到毒性终点后,动物接受了盐水或可胺.
- 血液动力学参数的持续监测和分析.
主要成果:
- 氧巴胺的使用显著增加了静缩压,静缩压和平均动脉压.
- 在用可巴胺治疗的组中观察到血液动力学改善.
- 两组之间没有发现死亡时间的显著差异.
结论:
- 氧巴胺在尼菲迪平诱导的休克中改善了血液动力学参数.
- 在这个模型中,氧巴胺并没有改善生存率.
- 氧巴胺可能是一种有用的辅助疗法,可以将患者连接到最终的护理.
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).